Co-immunoprecipitation (Co-IP) is an important technique that helps in confirming novel protein–protein interactions, thereby allowing the isolation of target proteins along with their interacting partner¹.

Co-immunoprecipitation is widely used to study protein–protein interactions in response to extracellular and intracellular stimuli. Additionally, it serves as a valuable tool for investigating protein-nucleic acid interactions and assessing how mutations impact protein binding affinity with its partner^{1, 2}.

Thus, Co-IP plays a pivotal role in proteomics, enabling the identification and characterization of protein complexes that are vital for cellular function. The changes in protein interaction patterns that lead to various disorders, including cancer, neurological diseases, and many infectious diseases, underscore the urgency and importance of research in this area. Co-IP has proven important in determining the molecular foundation of disease mechanisms, prospective biomarkers, and treatment targets. Co-IPs can be coupled with various detection methods like western blotting or mass spectrometry for identifying the process of protein–protein amplification of nucleic acid, or performing sequencing for the identification of protein-nucleic acid interaction².

Principle of co-immunoprecipitation

The concept of Co-IP is based on the principle of immunoprecipitation, which uses specialized antibodies to efficiently isolate proteins from any complex mixture³.

• Antibody binding: A specific antibody is employed to target the protein of interest within a complex biological sample. This antibody binds to the target protein, forming an antigen–antibody complex.
• Complex formation: The target protein often exists in association with other proteins within the cell. When the antibody binds to the target protein, it co-precipitates these interacting partners, effectively pulling down the entire protein complex from the solution.

The procedure is commonly performed with cell lysates, which are essentially a mixture of all cellular components released after the cell lysis, containing proteins, nucleic acids, and other biomolecules. The procedure entails incubating lysate with an antibody that is specific to the target protein in order to extract it and its associated binding partners. Further investigation of the isolated complex aids in identifying and analyzing the proteins involved in the interaction.

Co-immunoprecipitation methodology

Co-immunoprecipitation consists of three key steps: sample preparation, Co-IP assay, and elution⁴.

Sample preparation

Sample preparation requires the extraction of proteins from the cells, which is followed by preserving the interactions of these proteins. The first step towards the protein-rich extract is through cell lysis techniques.

Cell lysis can be done mechanically by homogenization or sonication, where physical disruption of the cell membrane allows the release of proteins. Alternatively, chemical methods can be used for detergents like NP-40 or Triton X-100. The detergents dissolve the cell membrane, allowing the proteins to be pulled out and retaining their native conformation.

The nature of the lysis technique would depend on the protein being studied, especially when it is a membrane protein. For example, membrane proteins are often more sensitive to denaturation and thus require gentle lysis conditions to maintain their functional state⁵.

Sample preparation should be performed using proper buffers. The choice between non-denaturing and denaturing buffers significantly impacts the outcome of Co-IP experiments:

• Non-denaturing buffers: These buffers maintain protein complexes in their native state, allowing for physiological interactions to be studied. For example, when studying protein complexes involved in signal transduction or cellular trafficking, non-denaturing buffers are preferred to preserve these multi-protein complexes. Commonly used non-denaturing buffers include phosphate-buffered saline (PBS) with mild detergents like Triton X-100⁶.
• Denaturing buffers: These may include strong detergents, reducing agents, and chaotropic agents that disrupt non-covalent interactions, causing protein denaturation. These buffers are valuable when studying proteins that may undergo conformational changes or when confirming interactions using methods like SDS-PAGE or mass spectrometry.

Denaturing buffers can help identify transient interactions or those that occur under extreme conditions, as they allow proteins to be unfolded and separated from complexes. An example of a denaturing buffer could contain urea or SDS, which breaks apart protein complexes to analyze individual components.

Procedure for co-immunoprecipitation assay

Preparation of the lysate is followed by incubation of the lysate with specific antibody. It allows the antibody to bind to its antigen; this will form the antibody-antigen complex. It is essential to maximize the efficiency of the binding step because incomplete binding results in the loss of interacting partners, leading to inaccurate results. The antibody should ideally be chosen based on its specificity to the target protein, ensuring that it can bind to the desired protein without cross-reacting with other proteins in the lysate.

After incubation, when the antibody has bound to its target protein, bead-based methods are employed for capturing antibody-protein complexes:

• Protein A/G beads: These beads are coated with either protein A or protein G, which bind to the Fc region of antibodies. The choice between them depends on the species and the isotype of the antibody used, as different antibodies have different Fc regions that may interact more effectively with either protein A or protein G.

For example, protein A binds better to IgG antibodies from rabbits and mice, while protein G prefers antibodies from humans or goats. Proper bead selection is required for optimal pull-down of antibody-protein complexes⁷.

• Magnetic/agarose beads: In addition to protein A/G beads, magnetic and agarose beads are also commonly used in Co-IP assays. Magnetic beads are particularly advantageous due to their ability to facilitate easy separation of the complexes by applying a magnetic field, which reduces the need for centrifugation. Alternatively, agarose beads provide a larger surface area, allowing for a higher binding capacity, making them suitable for high-abundance proteins or large protein complexes.

A significant challenge in Co-IP experiments is minimizing non-specific binding, which can introduce background noise and obscure true interactions. To mitigate this, several wash steps are performed using buffers with varying salt concentrations and detergents. These wash buffers help remove loosely associated proteins that may bind non-specifically to the antibody or beads.

For example, higher salt concentrations can help to dissociate weak, non-specific interactions, while detergents like Tween-20 aid in reducing hydrophobic interactions that could lead to non-specific binding. These rigorous wash steps ensure that only the specifically bound proteins remain in the final complex, allowing for a more accurate identification of protein–protein interactions.

Elution methods

After the capture of the protein complex, the next step involves elution of the protein from the beads. The elution techniques are categorized broadly into gentle and harsh techniques.

• Gentle elution techniques⁶: Aim to recover the protein complex without disrupting its native conformation or protein–protein interactions. This technique is majorly used when studying transient or weak interactions, where harsh conditions might cause dissociation of the complex and loss of valuable data.

One common gentle elution method is low pH elution, where acidic conditions are used to break the interaction between the antibody and the antigen without affecting the protein complex itself. For example, glycine buffers at pH 2.5–3.0 are commonly employed.

Another gentle method is competitive elution, where a free antigen or peptide that mimics the binding site of the target protein is used to competitively displace the protein from the antibody. This method preserves the interactions between the target protein and its binding partners, making it suitable for downstream applications like mass spectrometry or functional assays, where maintaining protein interactions is essential.

• Harsh elution techniques: Use strong detergents or high temperatures for complete dissociation of a protein complex from antibodies, but may disrupt sensitive interactions. These methods are useful when the goal is to fully denature the proteins and isolate individual components for analysis, such as in SDS-PAGE or when performing western blotting to confirm the presence of specific proteins.

Types of co-immunoprecipitation assay

There are different Co-IP assays, each with specific functions, advantages, and applications, depending on the experimental goals and the nature of the protein interactions being studied. The primary types include standard Co-IP, reverse Co-IP, and cross-linking enhanced Co-IP.

Standard co-immunoprecipitation

Standard Co-IP typically involves the isolation of the target protein, or the “bait,” and then the capture of its interaction partners, or the “prey.” The bait protein is primarily tagged with an affinity tag (eg, FLAG, His, or GST), and specific antibodies are used to capture the protein from the lysate. This technique is widely used when the researcher knows which protein is the primary target and wants to identify its interacting partners.

An example is using a tagged version of a transcription factor to pull down its co-regulatory proteins and study the components of a transcription complex.

Reverse co-immunoprecipitation

Reverse Co-IP allows to start with a known partner and pull down the initial target protein and associated proteins. This variation is excellent for validating interactions and delivering complementary insights into protein networks.

For example, if a researcher is studying the interaction between a protein kinase and its substrate, they might first isolate the known substrate protein and use reverse Co-IP to identify the kinase and other proteins that interact with it.

Cross-linking enhanced co-immunoprecipitation

In the cross-linking-enhanced Co-IP assay, cross-linking reagents are added to the cell lysate before Co-IP⁸. These reagents covalently link interacting proteins together, stabilizing weak or transient interactions that would otherwise be lost during the standard Co-IP procedure.

Cross-linking reagents such as dithiobis(succinimidyl propionate) (DSP) or bis(sulfosuccinimidyl) suberate (BS3) are commonly used to form covalent bonds between proteins in close proximity⁹. This technique significantly enhances detection sensitivity for weak or transient interactions.

For example, protein–protein interactions that occur only under specific conditions or at low affinities, like those involved in signaling cascades or molecular chaperone interactions, can be better preserved.

However, optimization needs to be carefully done to achieve stable cross-linked complexes or to break the native state of proteins. The ideal cross-linking conditions balance the preservation of genuine interactions while minimizing artifacts, which is important for the accurate study of protein networks.

Cross-linking also introduces additional steps in the procedure, such as the need to quench the cross-linking reaction after the binding step to prevent over-cross-linking, which can complicate downstream analysis.

Applications of co-immunoprecipitation

Co-immunoprecipitation has numerous applications in molecular biology, cell biology and diagnostics. Its ability to study protein interactions and complexes has made it indispensable in various research fields. Here are some of the most important applications of Co-IP:

Protein–protein interactions

Co-IP is one of the most essential methods for researching protein–protein interactions, which are fundamental to almost all cellular activities¹⁰. The partners to which a protein binds allow to determine its role in various cell activities such as signaling, metabolic control, and cell division. For example, in cancer research, Co-IP is often used to explore how oncogenes and tumor suppressor proteins interact with other proteins to promote cancer progression¹¹.

• Native vs. denatured protein interactions: Co-IP can be performed under native conditions (non-denaturing) or denaturing conditions. Native Co-IP preserves protein complexes in their functional state, allowing for the study of physiological interactions. For example, native Co-IP is useful for studying how proteins interact within multi-protein complexes, such as in transcriptional regulation¹².

Protein complex isolation and characterization

Apart from identifying interactions, Co-IP can also be used to separate whole protein complexes. It is beneficial in studies on multi-protein complexes. These come together in a coordinated fashion to produce complicated biological processes. Thus, defining such complexes leads to a better understanding of their function in health and disease. For example, the proteasome complex, responsible for degrading damaged or unneeded proteins, is composed of numerous subunits, and Co-IP can help isolate these components and study their roles in cellular homeostasis¹³.

Co-immunoprecipitation in signaling pathways

Co-IP is extremely useful for studying signaling pathways that include protein interactions in a particular order during signal transduction across the cell⁸. The Co-IP of these signaling proteins, along with the binding partners, would reveal the mechanisms underlying signals and thereby help in understanding the mechanism of the development of various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases, and the suitable step where intervention can be done. For example, studying the interaction of signaling molecules like Ras and RAF in the MAPK pathway using Co-IP can provide insights into tumorigenesis and potential therapeutic interventions¹⁴.

Applications in Diagnostics

In addition to its research applications, Co-IP has significant diagnostic potential. The technique can be used to detect and identify specific protein interactions in disease states, providing a tool for biomarker discovery. For example, identifying abnormal protein complexes involved in disease could serve as diagnostic markers for conditions such as Alzheimer’s disease or viral infections.

Co-IP can also be used in the development of targeted therapies by identifying vital protein interactions that are disrupted in disease, allowing for the design of drugs that restore or inhibit these interactions. This has been particularly important in the development of protein–protein interaction inhibitors for diseases like cancer, where disrupting specific PPIs can halt disease progression.

Advanced co-immunoprecipitation techniques

Co-immunoprecipitation can be enhanced by coupling with western blot analysis for specific protein detection, integrating mass spectrometry for comprehensive identification of co-precipitated proteins, and employing quantitative stable isotope labeling using amino acids in cell culture (SILAC) techniques to measure relative protein abundances in complex samples.

Co-immunoprecipitation coupled with western blot analysis

The most common technique used in combination with Co-IP is western blotting¹⁵. This combination allows for both qualitative and quantitative analysis of protein interactions. After the Co-IP procedure, SDS-PAGE is used to resolve the immunoprecipitated proteins, which are then transferred to a membrane to bind to the partner proteins that the antibodies are specific to. This allows for the detection and confirmation of protein–protein interactions in the form of bands that correlate with the molecular weight of the interacting partners.

Western blot analysis not only enables researchers to validate the interaction of specific proteins but also allows them to quantify the relative amounts of bound proteins, providing more detailed information on the strength of the interaction. For example, after pulling down a transcription factor, a researcher can use western blot to detect and quantify its interacting co-factors, helping to confirm the dynamics of gene regulation¹⁴.

Co-immunoprecipitation and mass spectrometry

Mass spectrometry offers an even more sensitive method for protein identification in a complex. Combining mass spectrometry with Co-IP allows the identification of known and novel interacting partners with high sensitivity and accuracy¹⁶.

By analyzing the co-precipitated proteins in the context of their molecular weight and peptide fragmentation patterns, mass spectrometry provides a comprehensive protein profile, making it invaluable for the discovery of previously unidentified interaction partners.

This approach is beneficial in large-scale proteomics studies where researchers aim to map out the interactome of a protein. For example, when studying a key signaling protein like AKT, combining Co-IP with MS can reveal both known and unexpected binding partners that may provide new insights into signaling pathways, cellular processes, or disease mechanisms¹⁷.

Quantitative co-immunoprecipitation using SILAC

For a better understanding of quantitative changes in protein interactions, SILAC can be used in conjunction with Co-IP¹⁸. SILAC involves incorporating stable isotope-labeled amino acids (eg, ^13C or ^15N) into proteins during synthesis.

By comparing the interaction profiles of proteins from labeled and unlabeled samples, researchers can quantitatively measure the changes in protein abundance or interaction strength. This method provides valuable information on how protein interactions change in response to different experimental conditions, such as drug treatments or genetic perturbations.

SILAC is particularly useful in studies where the relative abundance of proteins and their interaction dynamics need to be assessed. For example, when studying the effect of a small molecule on the interaction between tumor suppressor proteins or kinases, SILAC allows for a precise measurement of changes in protein interaction dynamics, offering insights into how specific perturbations affect cellular processes at the molecular level.

Other advanced techniques

Beyond western blot, mass spectrometry, and SILAC, fluorescence resonance energy transfer (FRET) and bioluminescence resonance energy transfer (BRET) can also be used in combination with Co-IP to study protein interactions in live cells or in real-time¹⁹. These techniques enable the visualization of protein–protein interactions in a more dynamic and spatially specific manner.

Troubleshooting and optimization in co-immunoprecipitation experiments

Common challenges in Co-IP experiments include low yield, high background noise, and non-specific binding. These issues can complicate the interpretation of results, but they can be addressed with various optimization strategies:

• Antibody selection: One of the most essential factors in Co-IP success is the use of high-quality antibodies. The antibodies should have validated specificity against bait or prey proteins, and their affinity should be strong enough to ensure effective binding. Pre-absorbing antibodies with irrelevant proteins or using monoclonal antibodies often improves specificity.
• Buffer composition: Adjusting the composition of lysis and washing buffers is essential to minimize non-specific binding while maximizing protein yield. The inclusion of detergents, salts, and protease inhibitors in the buffer can help maintain protein integrity while reducing background noise. For example, adding a higher concentration of salt in wash buffers can help eliminate weak interactions without disrupting stable binding.
• Incubation conditions: Optimizing incubation temperature and duration can improve antibody binding efficiency. Typically, incubations at 4°C for longer durations (eg, 1–4 hours or overnight) often yield better results, especially for weaker interactions. However, incubating at room temperature may be necessary for certain proteins or interactions.

Special considerations for co-immunoprecipitation experiments

Co-immunoprecipitation of membrane proteins requires specialized lysis buffers that preserve their integrity while facilitating solubilization. For low-abundance proteins, longer incubation times or larger sample volumes may be necessary to ensure effective capture. Additionally, employing reverse Co-IP as a complementary method can help validate interactions identified in standard assays by using antibodies against known interactors to confirm binding.

Data analysis and result interpretation

• Quantitative analysis: Co-IP data are most often examined by comparing band intensities using western blotting or mass spectrometry. Statistical analysis would be required to determine whether the difference seen between the experimental conditions is significant and thus reliable.
• Network analysis: Analyzing interaction networks helps visualize complex relationships among proteins within cellular pathways, providing insights into functional roles and regulatory mechanisms.
• Verification of results: Further independent verification often involves pull-down assays or fluorescence resonance energy transfers that validate the Co-IP results. The methodologies will enable the confirmation of the interactions between proteins occurring through Co-IP experiments, using further validation by way of other assay formats.

Future perspectives in co-immunoprecipitation research

• Emerging technologies: New technological innovations keep the Co-IP methods more potent with new scale studies of protein–protein interaction through high-throughput screening and new, improved specificity of antibodies, and other innovations in mass spectrometry and computational biology being made for complex interaction networks.
• Potential applications: Beyond the realm of basic research, the utility of Co-IP becomes even more enormous in the future for clinical applications. Because Co-IP can elucidate critical protein interactions crucial to disease, it potentially opens up new therapeutic avenues for diseases such as cancer, Alzheimer’s, and other diseases where malfunctioning of protein is integral to pathology.

FAQs

How does Co-IP differ from traditional immunoprecipitation?

Co-immunoprecipitation (Co-IP) differs from traditional immunoprecipitation (IP) primarily in its purpose and outcome. While IP isolates a specific target protein, Co-IP captures not only the target protein but also its interacting partners, allowing for the study of protein–protein interactions within a complex mixture. This distinction makes Co-IP particularly valuable for investigating protein complexes and signaling pathways.

What are some typical applications of Co-IP in molecular biology?

Co-immunoprecipitation (Co-IP) is a widely used molecular biology technique for studying protein–protein interactions, allowing the identification and analysis of biological signaling networks. It also facilitates protein complex isolation, enabling researchers to characterize their composition and function. Additionally, Co-IP helps investigate the kinetics of protein interactions within specific signaling pathways, enhancing our understanding of cellular processes and disease mechanisms.

What are the advantages of using Co-IP over other protein interaction techniques?

Co-immunoprecipitation (Co-IP) offers several advantages over other protein interaction techniques. It allows for the study of protein–protein interactions in their native conformation, maintaining physiological relevance. Co-IP can capture both the target protein and its interactors simultaneously, providing insights into complex biological networks. Additionally, it is versatile and can be combined with techniques like mass spectrometry for comprehensive analysis, making it a powerful tool for elucidating cellular mechanisms.

References

1.     van der Geer, P. Analysis of protein–protein interactions by coimmunoprecipitation. Methods in Enzymology. 541, 35–47 (2014).

2.     Sciuto, M. R., Warnken, U., Schnölzer, M., et al. Two-step coimmunoprecipitation (TIP) enables efficient and highly selective isolation of native protein complexes. Molecular & Cellular Proteomics. 17(5), 993–1009 (2018).

3.     Evans, I. M., Paliashvili, K. Co-immunoprecipitation assays. In VEGF Signaling: Methods and Protocols. 125–132, Springer US (2022).

4.     Lagundžin, D., Krieger, K. L., Law, H. C. H., et al. An optimized co-immunoprecipitation protocol for the analysis of endogenous protein-protein interactions in cell lines using mass spectrometry. STAR Protocols. 3(1), 101234 (2022).

5.     Alberts, B. Molecular Biology of the Cell (4th ed.). Garland Science (2002).

6.     Antrobus, R., Borner, G. H. Improved elution conditions for native co-immunoprecipitation. PLOS ONE. 6(3), e18218 (2011).

7.     Fishman, J. B., Berg, E. A. Protein A and protein G purification of antibodies. Cold Spring Harbor Protocols. 2019, pdb.prot099143 (2019).

8.     Lee, H. W., Kyung, T., Yoo, J., et al. Real-time single-molecule co-immunoprecipitation analyses reveal cancer-specific Ras signalling dynamics. Nature Communications. 4, 1505 (2013).

9.     Shi, J. M., Pei, J., Liu, E. Q., et al. Bis (sulfosuccinimidyl) suberate (BS3) crosslinking analysis of the behavior of amyloid-β peptide in solution and in phospholipid membranes. PLOS ONE. 12(3), e0173871 (2017).

10.  Iqbal, H., Akins, D. R., Kenedy, M. R. Co-immunoprecipitation for identifying protein-protein interactions in Borrelia burgdorferi. In Borrelia burgdorferi: Methods and Protocols. 47–55, Springer (2018).

11.  Sharifi Tabar, M., Francis, H., Yeo, D., et al. Mapping oncogenic protein interactions for precision medicine. International Journal of Cancer. 151(1), 7–19 (2022).

12.  Dwane, S., Kiely, P. A. Tools used to study how protein complexes are assembled in signaling cascades. Bioengineered Bugs. 2(5), 247–259 (2011).

13.  Tanaka, K. The proteasome: overview of structure and functions. Proceedings of the Japan Academy, Series B. 85(1), 12–36 (2009).

14.  Meeussen, J. V., Pomp, W., Brouwer, I., et al. Transcription factor clusters enable target search but do not contribute to target gene activation. Nucleic Acids Research. 51(11), 5449–5468 (2023).

15.  Lin, J. S., Lai, E. M. Protein–protein interactions: co-immunoprecipitation. In Bacterial Protein Secretion Systems: Methods and Protocols. 211–219, Springer (2017).

16.  Free, R. B., Hazelwood, L. A., Sibley, D. R. Identifying novel protein–protein interactions using co–immunoprecipitation and mass spectroscopy. Current Protocols in Neuroscience. 46(1), 5–28 (2009).

17.  Huang, B. X., Kim, H. Y. Effective identification of Akt interacting proteins by two-step chemical crosslinking, co-immunoprecipitation and mass spectrometry. PLOS ONE. 8(4), e61430 (2013).

18.  Ong, S. E., Blagoev, B., Kratchmarova, I., et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Molecular & Cellular Proteomics. 1(5), 376–386 (2002).

19.  El Khamlichi, C., Reverchon-Assadi, F., Hervouet-Coste, et al. Bioluminescence resonance energy transfer as a method to study protein-protein interactions: application to G protein coupled receptor biology. Molecules. 24(3), 537 (2019).